APA (7th ed.) Citation
(2026). Peptide‐directed nanovehicles enabling tumor‐selective ROS amplification and antitumor immunity. View.
Chicago Style (17th ed.) Citation
"Peptide‐directed Nanovehicles Enabling Tumor‐selective ROS Amplification and Antitumor Immunity." View 2026.
MLA (9th ed.) Citation
"Peptide‐directed Nanovehicles Enabling Tumor‐selective ROS Amplification and Antitumor Immunity." View, 2026.
Warning: These citations may not always be 100% accurate.